![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-34e5e18c09c5f80bd6435aa3be9344f6bd7315deac03fb0ece44875a2d56c0d6.jpg)
Apalutamide (Erleada) for Metastatic Castration-Sensitive Prostate Cancer - Details
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.